Stockreport

Outlook Therapeutics Increases Previously Announced Bought Deal Offering of Common Stock to $50 Million

Outlook Therapeutics, Inc.  (OTLK) 
Last outlook therapeutics, inc. earnings: 2/14 08:00 am Check Earnings Report
PDF ISELIN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a?late clinical-stage?biopharmaceutical company?wor [Read more]